The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients Under Mechanical Ventilation in ICU: Protocol for a Randomized, Open-Label, Controlled Trial

The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients Under Mechanical Ventilation in ICU: Protocol for a Randomized, Open-Label, Controlled Trial

Introduction: The most common physiological and psychological disorders associated with critical care patients are pain and anxiety. Sedatives and analgesics are commonly used to relieve these symptoms. However, the adverse effects of sedatives and analgesics are common and inevitable. As a new type...

Full description

Bibliographic Details
Main Authors: Shengjun Liu, Longxiang Su, Bo Zhang, Huaiwu He, Zunzhu Li, Qi Li, Qianlin Wang, Fang Smith, Yun Long
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Medicine
Subjects:
Remimazolam Besylate
ERAS
mechanical ventilation
intensive care unit
sedation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.735473/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.735473/full

Similar Items